ACE-536 Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS): Preliminary Results from a Phase 2 Study

被引：0

作者：

Platzbecker, Uwe ^{[1
]}

Germing, Ulrich ^{[2
]}

Giagounidis, Aristoteles ^{[3
]}

Goetze, Katharina ^{[4
]}

Kiewe, Philipp ^{[5
]}

Mayer, Karin ^{[6
]}

Ottman, Oliver ^{[7
]}

Radsak, Markus P. ^{[8
]}

Wolff, Thomas ^{[9
]}

Haase, Detlef ^{[10
]}

Hankin, Monty ^{[11
]}

Wilson, Dawn M. ^{[11
]}

Laadem, Adberrahmane ^{[12
]}

Sherman, Matthew L. ^{[11
]}

Attie, Kenneth M. ^{[11
]}

机构：

[1] Univ Klinikum Carl Gustav Carus, Dresden, Germany

[2] Univ Klinikum Dusseldorf, Dusseldorf, Germany

[3] Marien Hosp, Dusseldorf, Germany

[4] Tech Univ Munich, D-80290 Munich, Germany

[5] Onkol Schwerpunkt Oskar Helene Heim, Berlin, Germany

[6] Univ Klinikum Bonn, Bonn, Germany

[7] Klinikum JW Goethe Univ Frankfurt, Frankfurt, Germany

[8] Johannes Gutenberg Univ Mainz, Univ Med Ctr, D-55122 Mainz, Germany

[9] OncoRes Lerchenfeld UG, Hamburg, Germany

[10] Univ Med Gottingen, Gottingen, Germany

[11] Acceleron Pharma, Cambridge, MA USA

[12] Celgene Corp, Summit, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3